Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Prometheus Biosciences, Inc. (RXDX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19
   10-K10-KS-1/A
Revenues  3.11.211.0
            Revenue growth  154.6%-88.8% 
Cost of goods sold  0.00.011.0
Gross profit  3.11.20.0
            Gross margin  100.0%100.0%0.0%
Selling, general and administrative   [+]28.511.16.1
Research and development  62.419.1 
Other operating expenses    9.8
EBITDA   [+]-87.5-28.9-15.9
            EBITDA margin  -2797.9%-2351.3%-145.4%
Depreciation and amortization  0.30.10.0
EBIT   [+]-87.8-29.0-16.0
            EBIT margin  -2806.1%-2360.2%-145.7%
Interest expense, net   [+]0.82.10.8
Other income (expense), net   [+]-1.60.0 
Pre-tax income  -90.2-31.1-16.7
Income taxes  0.06.013.0
            Tax rate  0.0%  
Earnings from continuing ops  -90.2-31.1-29.7
Earnings from discontinued ops   -6.0-13.0
Net income  -90.2-37.1-29.7
            Net margin  -2882.6%-3021.8%-271.2%
   
Basic EPS   [+]($2.88)($20.77)($26.47)
Diluted EPS   [+]($2.88)($20.77)($26.47)
   
Shares outstanding (basic)   [+]31.31.51.1
Shares outstanding (diluted)   [+]31.31.51.1
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy